Whilst DPP4 over-expression in ovarian cancer tissues is well established [5,7], both pro- and anti-tumour effects have been attributed to DPP4 [6] and in vitro analyses have generated significant conflict surrounding its functional significance. This evidence concerns the gene DPP4 and ovarian carcinoma.